Cytochrome P450 2C9-CYP2C9.
Van Booven
Derek
D
Center for Pharmacogenomics at Washington University, St Louis, Missouri, USA.
Marsh
Sharon
S
McLeod
Howard
H
Carrillo
Michelle Whirl
MW
Sangkuhl
Katrin
K
Klein
Teri E
TE
Altman
Russ B
RB
D000483:Alleles; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D065729:Cytochrome P-450 CYP2C9; D064420:Drug-Related Side Effects and Adverse Reactions / Q000201:enzymology / Q000235:genetics; D004790:Enzyme Induction; D005787:Gene Frequency; D014644:Genetic Variation; D006801:Humans; D015394:Molecular Structure; D010597:Pharmacogenetics; D010641:Phenotype; D013379:Substrate Specificity
C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases